These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 24271715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Potentiation of BCNU-induced cytotoxicity and sister chromatid exchanges by dibromodulcitol in vitro.
    Pulst SM, Deen DF.
    Anticancer Res; 1990; 10(6):1647-50. PubMed ID: 2285238
    [Abstract] [Full Text] [Related]

  • 3. Mutagenicity of dibromodulcitol (DBD), an alkylating anticancer drug) and its mono- and bifunctional conversion products studied by the Salmonella/microsome assay.
    Tóth K, Sugár J, Somfai-Relle S, Hedegüs L.
    Carcinogenesis; 1982; 3(3):333-6. PubMed ID: 7044598
    [Abstract] [Full Text] [Related]

  • 4. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man--II. pharmacokinetics of DBD.
    Horváth IP, Csetényi J, Hindy I, Kerpel-Fronius S, Institoris I, Hegedüs I, Eckhardt S.
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1211-9. PubMed ID: 6891658
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and metabolism of dianhydrogalactitol DAG in patients: a comparison with the human disposition of dibromodulcitol DBD.
    Horváth IP, Csetényi J, Kerpel-Fronius S, Hegedüs L, Kanyár B, Eckhardt S.
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):163-71. PubMed ID: 3699079
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potentiation of antimetabolite action by dibromodulcitol in cell culture.
    Oláh E, Kremmer T, Boldizsár M.
    Adv Enzyme Regul; 1985 Feb; 24():155-75. PubMed ID: 3835819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The distribution of [3H]-dibromodulcitol in the central nervous system of patients with brain tumour.
    Csetényi J, Afra D, Kerpel-Fronius S, Horváth IP, Institoris L, Eckhardt S.
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1389-92. PubMed ID: 6685628
    [Abstract] [Full Text] [Related]

  • 12. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
    Zhang RX, Dougherty DV, Rosenblum ML.
    Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
    [Abstract] [Full Text] [Related]

  • 13. Decreased cell kill of vincristine and methotrexate against 9L rat brain tumor cells in vitro caused by alpha-difluoromethylornithine-induced polyamine depletion.
    Alhonen-Hongisto L, Hung DT, Deen DF, Marton LJ.
    Cancer Res; 1984 Oct; 44(10):4440-2. PubMed ID: 6432313
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.